Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K & S AG | SDF1 | Nov 19, 2024 | 5.40 | -0.92 |
K-BRO LINEN INC. | 74R | Nov 19, 2024 | 23.60 | +0.85 |
K-Fast Holding B | 6D90 | Nov 19, 2024 | 1.56 | -1.52 |
K. WAH INTL | KW2 | Nov 19, 2024 | 0.21 | 0.00 |
K2 Gold Corp | 23K | Nov 19, 2024 | 0.06 | +16.67 |
K2A KNAUST+ANDERSSON B | F70 | Nov 19, 2024 | 0.91 | 0.00 |
K9 Gold | 5GP0 | Nov 19, 2024 | 0.06 | +62.32 |
K92 Mining Inc | 92K | Nov 19, 2024 | 5.98 | +4.47 |
KA SHUI INTL | MI8 | Nov 19, 2024 | 0.02 | 0.00 |
Kadant, Inc. | KDA | Nov 19, 2024 | 374.00 | +1.08 |
Kaga Electronics Co. Ltd | 9V2 | Nov 19, 2024 | 16.40 | -0.61 |
Kagome Co Ltd Ordinary Shares (Japan) | 5EW | Nov 19, 2024 | 18.10 | +0.56 |
Kainos Group Plc | 1KG | Nov 19, 2024 | 9.40 | 0.00 |
Kairos Minerals Limited | YAJ | Nov 19, 2024 | 0.01 | +84.62 |
Kaiser Aluminum Corporation | KLU1 | Nov 19, 2024 | 75.50 | +0.67 |
Kaiser Reef Limited | 7YR | Nov 19, 2024 | 0.09 | -5.38 |
Kajima Corporation | KAJ | Nov 19, 2024 | 16.50 | +0.61 |
KaKaKu.com, Inc | KKC | Nov 19, 2024 | 13.90 | -3.47 |
Kala Pharmaceuticals | 27F0 | Nov 19, 2024 | 6.17 | -2.45 |
Kalamazoo Resources Limited | KR1 | Nov 19, 2024 | 0.04 | +0.47 |
Kalbe Farma Tbk | LCLA | Nov 19, 2024 | 0.08 | -1.27 |
KALI METALS ORD.F.P. O.N. | 6OB | Nov 19, 2024 | 0.07 | -4.35 |
Kalina Power LImited | WHS | Nov 19, 2024 | 0.00 | 0.00 |
KALMAR OYJ B | XK2 | Nov 19, 2024 | 30.62 | +0.66 |
Kalo Gold Corp | 0SX0 | Nov 19, 2024 | 0.02 | +52.00 |
Kalray SA | 3FS | Nov 19, 2024 | 0.90 | -4.66 |
Kaltura Inc | 73Q | Nov 19, 2024 | 1.89 | +2.16 |
KalVista Pharmaceuticals, Inc. | 4XC1 | Nov 19, 2024 | 8.35 | -5.11 |
Kamux | 4K8 | Nov 19, 2024 | 3.19 | -2.14 |
Kanabo Group Plc | 3WD | Nov 19, 2024 | 0.01 | +1 100.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.